| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $4,423,055 ) |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Allergy and Infectious Diseases Research | 000 | 4 | 4/24/2024 | NON-COMPETING CONTINUATION | $4,423,055 |
|
| Issue Date FY: 2023 ( Subtotal = $4,669,992 ) |
| 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Allergy and Infectious Diseases Research | 001 | 3 | 5/11/2023 | NON-COMPETING CONTINUATION | $0 |
| 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Allergy and Infectious Diseases Research | 000 | 3 | 4/21/2023 | NON-COMPETING CONTINUATION | $4,669,992 |
|
| Issue Date FY: 2022 ( Subtotal = $4,677,761 ) |
| 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Allergy and Infectious Diseases Research | 000 | 2 | 4/27/2022 | NON-COMPETING CONTINUATION | $4,677,761 |
|
| Issue Date FY: 2021 ( Subtotal = $4,904,730 ) |
| 2021 | 2021 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Allergy and Infectious Diseases Research | 000 | 1 | 8/13/2021 | NEW | $4,904,730 |
|
|